Autoantibodies as potential biomarkers for nasopharyngeal carcinoma
- 24 July 2008
- journal article
- Published by Wiley in Proteomics
- Vol. 8 (15), 3185-3193
- https://doi.org/10.1002/pmic.200700651
Abstract
Autoantibody signatures, as new biomarkers, may improve the early detection of nasopharyngeal carcinoma (NPC). We constructed a T7 phage cDNA library from mixed NPC tissues, and we isolated 31 tumor‐associated proteins using biopan enrichment techniques with sera from NPC patients and from healthy population. DNA sequence analysis showed that among 31 phage‐displayed proteins, 22 have sequence identity with known or putative tumor‐associated proteins. The results of immunochemical reactivity of patients' sera with phage‐expressed proteins showed enrichment in the number of immunogenic phage clones in the biopanning process and also confirmed that antibodies were present in the sera of patients but not in the sera of healthy donors. The autoantibody against phage‐expressed protein MAGE, HSP70, Fibronectin, and CD44 measured by ELISA had greater predictive value than that against EBNA‐1, respectively. The antibody levels against MAGE in sera positively correlated with the clinical stages of NPC, and the antibody levels against other three proteins partly correlated with the clinical stages of NPC. Our studies suggested that the autoantibodies against tumor‐associated antigens in the sera of NPC patients could be used as a screening test for NPC. Studies of the corresponding proteins may have significances in tumor biology, novel drug development, and immunotherapy.Keywords
This publication has 28 references indexed in Scilit:
- The management of neck metastases in nasopharyngeal cancerCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2007
- The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer CellsNew England Journal of Medicine, 2007
- New perspectives on an old disease: proteomics in cancer researchGenome Biology, 2007
- Lung cancer risk prediction: A tool for early detectionInternational Journal of Cancer, 2006
- Bmi-1 Is a Novel Molecular Marker of Nasopharyngeal Carcinoma Progression and Immortalizes Primary Human Nasopharyngeal Epithelial CellsCancer Research, 2006
- Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancerProteomics, 2005
- Les carcinomes du nasopharynx : données actuellesPathologie Biologie, 2005
- Prospective validation of serum CYFRA 21‐1, β‐2‐microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapyCancer, 2004
- The case for early detectionNature Reviews Cancer, 2003
- The Hallmarks of CancerCell, 2000